← Browse by Condition
Medical Condition

recurrent burkitt lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT01371630 Phase 1, Phase 2
Recruiting

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

Enrollment
276 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →